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Abstract
Mutations in the Cu/Zn superoxide dismutase (Sod1) gene have been reported to cause adult-onset
autosomal dominant Amyotrophic Lateral Sclerosis (FALS). In sporadic cases (SALS) de novo
mutations in the Sod1 gene have occasionally been observed. The recent finding of a mutation in
the VAMP/synaptobrevin-associated membrane protein B (VAPB) gene as the cause of
amyotrophic lateral sclerosis (ALS8), prompted us to investigate the entire coding region of this
gene in SALS patients. One hundred twenty-five unrelated patients with adult-onset ALS and 150
healthy sex-age-matched subjects with the same genetic background were analyzed.
Genetic analysis for all exons of the VAPB gene by DHPLC revealed 5 variant profiles in 83 out of
125 SALS patients. Direct sequencing of these PCR products revealed 3 nucleotide substitutions.
Two of these were found within intron 3 of the gene, harbouring 4 variant DHPLC profiles. The
third nucleotide variation (Asp130Glu) was the only substitution present in the coding region of
the VAPB gene, and it occurred within exon 4. It was found in three patients out of 125. The
frequency of the detected exon variation in the VAPB gene was not significantly different between
patients and controls. In conclusion, our study suggests that VAPB mutations are not a common
cause of adult-onset SALS.
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Findings
Amyotrophic Lateral Sclerosis (ALS) is a progressive lethal
disorder of motor neurons of the spinal cord and brain.
More than 90% of ALS patients are sporadic (SALS), not
showing any familial trait. Approximately 10% of cases
are familial (FALS), and within these lie several distinct
forms of the disease. The most common form of FALS is
autosomal dominant for which to date 2 genes have been
identified: ALS1, with adult-onset caused by mutations in
the gene encoding the cytosolic antioxidant enzyme Cu,
Zn-superoxide dismutase (Sod1) [1,2]; and ALS4, a rare
juvenile-onset disorder, associated with mutations of the
senataxin gene (SETX) [3]. An autosomal recessive, juve-
nile-onset form (ALS2), has been associated with muta-
tions of the Alsin gene located at 2q33 [4]. To date over
100 different missense mutations in the Sod1 gene [5] and
up to eight described mutations in the Alsin gene have
been reported [6].
By contrast, sporadic ALS is believed to be a multi-facto-
rial disease in which modifying genes and environmental
agents affect its clinical manifestation, but few associated
genes have so far been identified [7-13]. De novo muta-
tions in the Sod1  gene have only occasionally been
observed in sporadic cases of ALS suggesting that muta-
tions in this gene are a rare cause of non familial forms of
ALS [14,15].
The finding by Nishimura et al.[16] of a missense muta-
tion in the VAMP/synaptobrevin-associated membrane
protein B (VAPB) gene in autosomal dominant motoneu-
ron diseases (ALS8), prompted us to investigate the entire
coding region of this gene in 125 SALS patients.
Following informed consent, blood was taken from 125
unrelated Caucasian patients from Southern Italy, who
fulfilled the El Escorial criteria [17] for ALS. Samples were
also taken from 150 controls, matched for age, sex and
geographic region. Clinical information is provided in
Table 1. Lymphocyte DNA was extracted from blood sam-
ples using standard procedure. Sod1  mutation-negative
patients were screened using primer flanking the intron-
exon regions of the VAPB gene. The PCR products were
analyzed by Denaturing High Performance Liquid Chro-
matography (DHPLC) on a WAVE Nucleic Acid Fragment
Analysis System (Transgenomic Inc., Mountain View,
CA). Representative samples with abnormal profile in
DHPLC were sequenced by the ABI Prism BigDye Termi-
nator cycle sequencing ready reaction kit (Perkin Elmer-
Applied Biosystems Inc., Foster City, CA).
DHPLC analysis of the VAPB gene [GenBank accession
no. AL035455] detected five variant profiles in 83 out of
125 SALS patients. Direct sequencing of PCR products
revealed 3 nucleotide substitutions. Two nucleotide sub-
stitutions, g.134585C>T and g.134688A>G were found
within intron 3 of the gene, harbouring 4 variant DHPLC
profiles, because of their combination in homozygous or
heterozygous states. These polymorphisms were already
present in the SNP database as rs 2234487 and rs
2234488, respectively [18].  The frequencies in our SALS
patients and in control population were 65% vs 64% for
the rs 2234487 and 42% vs 45% for the rs 2234488,
respectively.
The third nucleotide substitution was the only substitu-
tion present in the coding region of the VAPB gene and it
occurred within exon 4 at nucleotide g.138864T>G
(Asp130Glu).
The Asp130Glu variation is located between MSP and
Coiled-coil domains, and involves an aminoacid residue
of aspartic acid not conserved among different species. We
identified this variation in heterozygous state in three out
of 125 SALS patients (2.0%) and in three of 150 (2.4%)
sex-age-matched healthy subjects from the same geo-
graphical area, suggesting that this aminoacidic substitu-
tion is not causative of the disease.
The data presented herein suggest that VAPB mutations
are not a common cause of adult-onset SALS in Italian
population. Further, the novel nucleotide variation iden-
tified in exon 4 of VAPB gene represents a polymorphism,
probably linked to a restrict geographic area.
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